Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB18441 | Maplirpacept | 2 | Recruiting | 1 |
DB17116 | Ontorpacept | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Recruiting | 1 |